Adma Biologics Inc
NASDAQ:ADMA 4:00:00 PM EDT
| Market Cap (Intraday) | 4.70B |
| Current PE | 135.21 |
| Forward PE | 42.04 |
| 2yr Forward PE | 30.58 |
| 10-Day MA | $19.79 |
| 50-Day MA | $17.24 |
| 200-Day MA | $10.01 |
Adma Biologics Inc Stock, NASDAQ:ADMA
465 State Route 17 South, Ramsey, New Jersey 07446
United States of America
Phone: +1.201.478.5552
Number of Employees: 624
Description
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.